134 related articles for article (PubMed ID: 26917481)
21. [Antimicrobial peptide LL-37 in macrophages promotes colorectal cancer growth].
Pan XH; Quan WW; Wu JL; Xiao WD; Sun ZJ; Li D
Zhonghua Zhong Liu Za Zhi; 2018 Jun; 40(6):412-417. PubMed ID: 29936765
[No Abstract] [Full Text] [Related]
22. Antimicrobial Activities of LL-37 Fragment Mutant-Poly (Lactic-Co-Glycolic) Acid Conjugate against
Mori T; Yoshida M; Hazekawa M; Ishibashi D; Hatanaka Y; Nagao T; Kakehashi R; Kojima H; Uno R; Ozeki M; Kawasaki I; Yamashita T; Nishikawa J; Uchida T
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34065861
[TBL] [Abstract][Full Text] [Related]
23. Anti-fungal activity of cathelicidins and their potential role in Candida albicans skin infection.
López-García B; Lee PH; Yamasaki K; Gallo RL
J Invest Dermatol; 2005 Jul; 125(1):108-15. PubMed ID: 15982310
[TBL] [Abstract][Full Text] [Related]
24.
Hsu CM; Liao YL; Chang CK; Lan CY
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638975
[No Abstract] [Full Text] [Related]
25. Candida albicans SC5314 inhibits NLRP3/NLRP6 inflammasome expression and dampens human intestinal barrier activity in Caco-2 cell monolayer model.
Mao X; Qiu X; Jiao C; Lu M; Zhao X; Li X; Li J; Ma J; Zhang H
Cytokine; 2020 Feb; 126():154882. PubMed ID: 31629100
[TBL] [Abstract][Full Text] [Related]
26. Therapeutic use of a cationic antimicrobial peptide from the spider Acanthoscurria gomesiana in the control of experimental candidiasis.
Rossi DC; Muñoz JE; Carvalho DD; Belmonte R; Faintuch B; Borelli P; Miranda A; Taborda CP; Daffre S
BMC Microbiol; 2012 Mar; 12():28. PubMed ID: 22394555
[TBL] [Abstract][Full Text] [Related]
27. Expression of a novel dual-functional protein--the antimicrobial peptide LL-37 fused with human acidic fibroblast growth factor in Escherichia coli.
Shen J; Lu XM; Jin XB; Ding J; Li XB; Mei HF; Chu FJ; Zhu JY
Protein Expr Purif; 2012 Jan; 81(1):119-125. PubMed ID: 21963769
[TBL] [Abstract][Full Text] [Related]
28. Expression in Escherichia coli of novel recombinant hybrid antimicrobial peptide AL32-P113 with enhanced antimicrobial activity in vitro.
Wanmakok M; Orrapin S; Intorasoot A; Intorasoot S
Gene; 2018 Sep; 671():1-9. PubMed ID: 29859288
[TBL] [Abstract][Full Text] [Related]
29. Activation of HIF-1α and LL-37 by commensal bacteria inhibits Candida albicans colonization.
Fan D; Coughlin LA; Neubauer MM; Kim J; Kim MS; Zhan X; Simms-Waldrip TR; Xie Y; Hooper LV; Koh AY
Nat Med; 2015 Jul; 21(7):808-14. PubMed ID: 26053625
[TBL] [Abstract][Full Text] [Related]
30. Antimicrobial peptide LL-37 disrupts plasma membrane and calcium homeostasis in
Chen S-Y; Chang C-K; Lan C-Y
Microbiol Spectr; 2023 Dec; 11(6):e0255123. PubMed ID: 37888991
[No Abstract] [Full Text] [Related]
31. Interleukin-18 and gamma interferon production by oral epithelial cells in response to exposure to Candida albicans or lipopolysaccharide stimulation.
Rouabhia M; Ross G; Pagé N; Chakir J
Infect Immun; 2002 Dec; 70(12):7073-80. PubMed ID: 12438388
[TBL] [Abstract][Full Text] [Related]
32. Interleukin 13 exposure enhances vitamin D-mediated expression of the human cathelicidin antimicrobial peptide 18/LL-37 in bronchial epithelial cells.
Schrumpf JA; van Sterkenburg MA; Verhoosel RM; Zuyderduyn S; Hiemstra PS
Infect Immun; 2012 Dec; 80(12):4485-94. PubMed ID: 23045480
[TBL] [Abstract][Full Text] [Related]
33. Human cathelicidin peptide LL-37 modulates the effects of IFN-gamma on APCs.
Nijnik A; Pistolic J; Wyatt A; Tam S; Hancock RE
J Immunol; 2009 Nov; 183(9):5788-98. PubMed ID: 19812202
[TBL] [Abstract][Full Text] [Related]
34. [Prokaryotic expression and function detection of Mycobacterium tuberculosis Hsp16.3].
Qin H; Gao S; Yuan J; Xu L; Luo J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 May; 30(5):480-4. PubMed ID: 24796742
[TBL] [Abstract][Full Text] [Related]
35. Antibacterial effect of human mesenchymal stem cells is mediated in part from secretion of the antimicrobial peptide LL-37.
Krasnodembskaya A; Song Y; Fang X; Gupta N; Serikov V; Lee JW; Matthay MA
Stem Cells; 2010 Dec; 28(12):2229-38. PubMed ID: 20945332
[TBL] [Abstract][Full Text] [Related]
36. In vitro mechanisms of interleukin-8-mediated responses of human gingival epithelial cells to Candida albicans infection.
Egusa H; Nikawa H; Makihira S; Yatani H; Hamada T
Int J Med Microbiol; 2006 Aug; 296(4-5):301-11. PubMed ID: 16545602
[TBL] [Abstract][Full Text] [Related]
37. [Mechanisms of antimicrobial peptide LL-37 in macrophage-promoted ovarian cancer cell proliferation].
Li D; Wang X; Dai Y; Yang F; Wan HY
Zhonghua Zhong Liu Za Zhi; 2013 Sep; 35(9):660-5. PubMed ID: 24332052
[TBL] [Abstract][Full Text] [Related]
38. Altered immune responses in patients with chronic mucocutaneous candidiasis.
Khosravi AR; Shokri H; Darvishi S
J Mycol Med; 2014 Jun; 24(2):135-40. PubMed ID: 24582143
[TBL] [Abstract][Full Text] [Related]
39. LL-37 Triggers Antimicrobial Activity in Human Platelets.
Sánchez-Peña FJ; Romero-Tlalolini MLÁ; Torres-Aguilar H; Cruz-Hernández DS; Baltiérrez-Hoyos R; Sánchez-Aparicio SR; Aquino-Domínguez AS; Aguilar-Ruiz SR
Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769137
[TBL] [Abstract][Full Text] [Related]
40. [Establishment and evaluation of a double antibody sandwich ELISA to detect Csa2 protein of Candida albicans].
Liu L; Cai J; Liu C; Guo Y; Pan Y; Wang Y; Che X
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Jul; 30(7):732-5. PubMed ID: 25001939
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
